Contact Details
T: + 66 2 264 8000
F:
Email:  |
Tanapong Damkerngkhajornwong is an associate in the mergers and acquisitions
practice group at Weerawong C&P. He advises domestic and international clients on mergers,
acquisitions and joint ventures involving listed and non-listed companies, including tax
matters. Recent
Experience Representation of Global Power
Synergy Public Company Limited (GPSC), the power flagship company of the PTT Group, in the
restructuring of GPSC’s battery business by transferring the battery business (both shares and
assets) to Nuovo Plus Co., Ltd., a joint venture company with Arun Plus Co., Ltd. (a wholly-owned
subsidiary of PTT Public Company Limited (PTT)) with a view to a greater expansion of the battery
business both in Thailand and outside Thailand. The transaction value was THB 2,428 million. The
deal was signed in February 2022 and closed in April
2022.
Representation of SCB
Securities Co., Ltd., a subsidiary of The Siam Commercial Bank Public Company Limited, in
relation to the proposed acquisition of 51% interest in Bitkub Online Co., Ltd. (Bitkub), a leading
digital asset exchange in Thailand, from Bitkub Capital Group Holdings Co., Ltd. The transaction
value is worth approximately THB 17.85 billion. The total market capitalization of Bitkub is THB 35
billion, marking another Thai "unicorn". The investment in Bitkub is based on the recognition of
significant growth opportunities in the digital asset business and will enable SCBS, as a major
shareholder, to further develop the digital asset ecosystem in Thailand. The deal was signed on 2
November 2021 and is expected to be completed by the first quarter of
2022.
Representation
of Frasers Property (Thailand)
Public Company Limited (FPT), on the acquisition of the
entire share capital of TCCCL Sena Co., Ltd. (TCCCL Sena), the developer of The Royal Residence, a
luxury residential project in Bangkok, through Sathorn Property Management Co., Ltd., in which FPT
holds a 100% equity stake and indirectly becomes the major shareholder of TCCCL Sena. The
transaction was valued at THB 591 million and closed on 2 December 2021. Representation of Cardinal Health, a leading
pharmaceuticals distributor, in its disposal of the Cordis business, which develops and manufactures
cardiology and endovascular technology, in Thailand to a private equity firm Hellman & Friedman
(H&F) through an asset sale. The transaction was part of Cardinal Health’s global disposal of
the Cordis business which was valued at approximately USD 1 billion. The deal signed in March 2021
and closed in August 2021. |
EducationLL.M. Advanced Studies in EU Tax Law, Leiden University, the Netherlands, 2016
LL.B. (Honors), Chulalongkorn University, 2011 LanguagesThai, English |
